<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="brief-report" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Modern Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Modern Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Современная онкология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1815-1434</issn><issn publication-format="electronic">1815-1442</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">70287</article-id><article-id pub-id-type="doi">10.26442/18151434.2021.1.200820</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL ONCOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ОНКОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Systemic treatments for metastatic cutaneous melanoma (Russian Translation of Cochrane Plain Language Summary – PLS)</article-title><trans-title-group xml:lang="ru"><trans-title>Системное лечение метастатической кожной меланомы (перевод на русский язык резюме на простом языке Кокрейновского систематического обзора)</trans-title></trans-title-group></title-group><pub-date date-type="pub" iso-8601-date="2021-05-19" publication-format="electronic"><day>19</day><month>05</month><year>2021</year></pub-date><volume>23</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>43</fpage><lpage>44</lpage><history><date date-type="received" iso-8601-date="2021-05-06"><day>06</day><month>05</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-05-06"><day>06</day><month>05</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://modernonco.orscience.ru/1815-1434/article/view/70287">https://modernonco.orscience.ru/1815-1434/article/view/70287</self-uri><abstract xml:lang="en"><p>This publication is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review: Pasquali S, Hadjinicolaou AV, Chiarion Sileni V, Rossi CR, Mocellin S. Systemic treatments for metastatic cutaneous melanoma. Cochrane Database of Systematic Reviews 2018, Issue 2. Art. No.: CD011123. DOI: 10.1002/14651858.CD011123.pub2</p></abstract><trans-abstract xml:lang="ru"><p>Эта публикация является переводом на русский язык резюме на простом языке Кокрейновского систематического обзора «Системное лечение метастатической кожной меланомы». Оригинальная публикация: Pasquali S, Hadjinicolaou AV, ChiarionSileni V, Rossi CR, Mocellin S. Systemic treatments for metastatic cutaneous melanoma. Cochrane Database of Systematic Reviews 2018, Issue 2. Art. No.: CD011123. DOI: 10.1002/14651858.CD011123.pub2.</p></trans-abstract><kwd-group xml:lang="en"><kwd>angiogenesis Inhibitors</kwd><kwd>antibodies</kwd><kwd>monoclonal</kwd><kwd>antineoplastic agents</kwd><kwd>brain neoplasms</kwd><kwd>CTLA-4 antigen</kwd><kwd>disease-free survival</kwd><kwd>drug therapy</kwd><kwd>combination</kwd><kwd>immunotherapy</kwd><kwd>interferon-alpha</kwd><kwd>interleukin-2</kwd><kwd>melanoma</kwd><kwd>programmed cell death 1 receptor</kwd><kwd>proto-oncogene proteins B-RAF</kwd><kwd>randomized controlled trials as topic</kwd><kwd>skin neoplasms</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>ингибиторы ангиогенеза</kwd><kwd>антитела</kwd><kwd>моноклональные</kwd><kwd>противоопухолевые средства</kwd><kwd>новообразования головного мозга</kwd><kwd>антиген CTLA-4</kwd><kwd>выживание без болезней</kwd><kwd>медикаментозная терапия</kwd><kwd>комбинированная</kwd><kwd>иммунотерапия</kwd><kwd>интерферон-альфа</kwd><kwd>интерлейкин-2</kwd><kwd>меланома</kwd><kwd>рецептор запрограммированной гибели клеток 1</kwd><kwd>протоонкогенные белки B-RAF</kwd><kwd>рандомизированные контролируемые испытания как тема</kwd><kwd>новообразования кожи</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list/></back></article>
